Pulmonx Corp: PRIMECAP MANAGEMENT CO amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
PRIMECAP Management Co. filed an amended Schedule 13G with the SEC (accession 0000763212-26-000032) updating its ownership stake in Pulmonx Corp. The filing, submitted under the SEC's beneficial ownership reporting rules, revises the investment adviser's previously disclosed position in the medical device maker. Specific share counts and percentage figures were not detailed in the filing headline. The amendment matters because 13G updates signal shifts in large institutional holdings that can influence Pulmonx's shareholder base and governance. Investors will watch for the full filing details to gauge whether PRIMECAP increased or trimmed its stake.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
PRIMECAP Management Co, Pulmonx Corp